Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sunshine Lake Pharma Co., Ltd. Class H ( (HK:6887) ) has issued an announcement.
Sunshine Lake Pharma Co., Ltd. has announced that its board of directors will meet on August 29, 2025, to review and approve the company’s interim financial results for the first half of the year ending June 30, 2025. The meeting will also consider the potential payment of an interim dividend, which could impact stakeholders and signal the company’s financial health and strategic direction.
More about Sunshine Lake Pharma Co., Ltd. Class H
Sunshine Lake Pharma Co., Ltd. is a pharmaceutical company based in the People’s Republic of China. It operates in the healthcare industry, focusing on the development and production of pharmaceutical products.
Average Trading Volume: 2,281,849
For a thorough assessment of 6887 stock, go to TipRanks’ Stock Analysis page.